Connect with us

Latest News

J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report

Published

on

J&J’s revenue of $24.8 billion rose 10.8%, mostly driven by $1.82 billion in international sales of its Covid vaccine.

Continue Reading
Comments